Research

Published Research Matters

Therapeutic Efficacy of CD34-Derived Allogeneic Dendritic Cells Engineered to Express CD93, CD40L, and CXCL13 in Humanized Mouse Models of Pancreatic Cancer

Large scale serum proteomics identifies proteins associated with performance decline and clinical milestones in Duchenne muscular dystrophy

Broad Institute Machine Learning in Drug Discovery Symposium

Drivers of mortality in COVID ARDS depend on patient sub-type

MOA Miner Publication Case Study

Toronto Machine Learning Summit (TMLS) presentation – June 12-14, 2023

Poster Presentation – Muscular Dystrophy Association Clinical & Scientific Conference March 19 – 22, 2023

Poster Presentation – Society for Laboratory Automation and Screening (SLAS) 2023 International Conference and Exhibition

Discriminating Acute Respiratory Distress Syndrome from other forms of respiratory failure

Poster Presentation – American Epilepsy Society (AES) 2022

Phenotype-Driven Identification of Drug Targets For Post-COVID-19 Anosmia

Drivers of Mortality in COVID ARDS Depend on Patient Sub-Type

C reactive protein utilisation, a biomarker for early COVID-19 treatment

Paper - Using iterative Machine Learning (Contingent-AI) in a clinical setting

White Paper - Using AI to Discover Target and MOA Prediction Using HCI Screen

Poster Presentation - MIT AI in Drug Discovery Conference2020

MOA Analysis for Rare Cancer (Pre-Print - bioRxiv)

The Lancet Study on COVID-19 featuring BioSymetrics